Recall Notices
Epinephrine Nasal Solution - FDA Warning
January 22, 2025
On Jan. 16, 2025, the FDA warned healthcare professionals not to use unapproved epinephrine nasal solutions from BPI Labs and Endo
One Lot of Xembify Withdrawn
January 17, 2025
On Jan. 13, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial
Systane Eye Drops Recalled
December 30, 2024
On Dec. 21, 2024, Alcon Laboratories recalled one lot of Systane® Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count to the consumer level.
Adrenalin Recalled
December 30, 2024
On Dec. 20, 2024, Endo, Inc., the parent company of Par Pharmaceutical, recalled six lots of Adrenalin® Chloride Solution
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.